valine has been researched along with Kidney Failure, Chronic in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (11.36) | 18.7374 |
1990's | 4 (4.55) | 18.2507 |
2000's | 37 (42.05) | 29.6817 |
2010's | 34 (38.64) | 24.3611 |
2020's | 3 (3.41) | 2.80 |
Authors | Studies |
---|---|
Abdelghani, R; Elkholy, S; Elmeligui, A; Farouk, F; Ibahim, S; Mogawer, S; Wahba, D | 1 |
Cheema, SS; Cheema, SUR; Gilani, N; Hussain, G; Rehman, MS | 1 |
Akhan, S; Ergun, NC; Köse, Ş; Onlen, Y; Tatar, B; Turken, M; Yılmaz, Y | 1 |
Feng, Z; Gao, H; Huang, R; Li, Z; Liang, X; Lin, T; Liu, S; Ma, J; Wang, X; Xu, L; Zhang, L | 1 |
Abd-Elsalam, S; Abo-Amer, YE; Ahmed, R; Badawi, R; El-Abgeegy, M; Elguindy, AMA; Elkadeem, M; Elsergany, HF; Elshweikh, SA; Hawash, N; Mansour, L; Mohmed, AA; Soliman, MY; Soliman, S | 1 |
Bhamidimarri, KR; Burke, G; Chen, L; Ciancio, G; Guerra, G; Kupin, W; Ladino, M; Martin, P; Mattiazzi, A; Pedraza, F; Roth, D | 1 |
McIsaac, M; Prasad, B; Toppings, J | 1 |
Cole, J; Stark, JE | 1 |
Chen, TY; Dong, J; Gao, H; He, YL; Hu, CH; Liu, JF; Ren, DF; Yan, TT; Yang, SJ; Yang, Y; Zhao, YR; Zhu, L | 1 |
Chawla, Y; De, A; Dhiman, RK; Duseja, A; Gupta, KL; Kohli, HS; Kumar, V; Mehta, M; Ramachandran, R; Taneja, S | 1 |
Aoufi-Rabih, S; Fabrizi, F; García-Agudo, R; González-Corvillo, C; Salgueira-Lazo, M | 1 |
Chmelova, K; Frankova, S; Kreidlova, M; Merta, D; Senkerikova, R; Sperl, J | 1 |
Arai, K; Honda, M; Horii, R; Iida, N; Kaneko, S; Kawaguchi, K; Kitahara, M; Kitamura, K; Mizukoshi, E; Nio, K; Orita, N; Sakai, Y; Shimakami, T; Sunagozaka, H; Takatori, H; Terashima, T; Yamashita, T | 1 |
Abdel-Aziz, EM; Abdel-Malek, MO; Hashim, AA; Hetta, HF; Mekky, MA; Morsy, KH; Osman, HA | 1 |
Altıntaş, E; Ateş, F; Özdoğan, O; Sezgin, O; Üçbilek, E; Yaraş, S | 1 |
Althoff, CE; Bergfeld, L; Brakemeier, S; Budde, K; Duerr, M; Eckardt, KU; Glander, P; Halleck, F; Lehner, LJ; Marticorena Garcia, SR; Sack, I; Schrezenmeier, EV | 1 |
Boyacıoğlu, AS; Çolak, T; Dağlı, Ü; Haberal, M; Hilmioğlu, F; Öcal, S; Özer Etik, D; Selçuk, H; Suna, N | 1 |
Ando, I; Fujiwara, M; Imai, Y; Oguma, S; Sato, H; Sekino, H; Takeuchi, K | 1 |
Choovichian, P; Leelasiri, K; Satirapoj, B; Supasyndh, O | 1 |
Alcorn, H; Bertz, R; Bifano, M; Garimella, T; Hwang, C; Kandoussi, H; Luo, WL; Marbury, TC; Sherman, D; Wang, R | 1 |
Ando, I; Fujiwara, M; Imai, Y; Oguma, S; Sato, H; Sato, K; Sekino, H; Takeuchi, K | 1 |
Iio, E; Ishikawa, T; Kumada, T; Tada, T; Takaguchi, K; Tanaka, Y; Toyoda, H; Tsuji, K; Zeniya, M | 1 |
Abunimeh, M; Bennett, M; Bernstein, DE; Cohen, DE; Cohen, E; Khatri, A; Lawitz, E; Mantry, PS; Pockros, PJ; Podsadecki, T; Reddy, KR; Shulman, NS; Sulkowski, MS; Wang, D | 1 |
Ackens, R; Posthouwer, D | 1 |
Burger, D; Gevers, TJ; Kooistra, MP; Richter, C; Schipper-Reintjes, E | 1 |
Ikeda, A; Nakatani, M; Takahashi, R; Tsukino, M | 1 |
D'Offizi, G; Gasbarrini, A; Gianserra, L; Lionetti, R; Pasquazzi, C; Pompili, M; Ponziani, FR; Siciliano, M | 1 |
Baier, M; Bambauer, R; Handrock, R; Kirchertz, EJ; Leidig, M; Leinung, D; Schmieder, RE; Szabã, T | 1 |
Galle, J | 1 |
Araki, R; Ikeda, N; Inoue, T; Kanno, Y; Shoda, J; Sugahara, S; Suzuki, H; Takenaka, T | 1 |
Hara, K; Itoh, H; Nagashima, S; Suyama, K | 1 |
Asahi, T; Okazawa, S; Okudera, H; Takahashi, C; Tange, D; Tokui, K; Tsutsui, M; Wakasugi, M | 1 |
Azuma, K; Dejima, T; Ishigami, T; Kokuho, T; Masuda, S; Mitsuhashi, H; Okano, Y; Ozawa, M; Shigenaga, A; Sugano, T; Tamura, K; Tokita, Y; Toya, Y; Tsurumi-Ikeya, Y; Uchino, K; Umemura, S; Wakui, H | 1 |
Furuyama, M; Hashimoto, T; Hayasaka, K; Matsunaga, A; Ogino, D; Toyoda, K | 1 |
Gelber, AC | 1 |
Ecder, T; Kashihara, N; Locatelli, F; Palmer, BF | 1 |
Akl, A; Blancho, G; Cantarovich, D; Dantal, J; Giral, M; Leone, F; Soulillou, JP | 1 |
Kambhampati, G; Kazory, A; Pakkivenkata, U | 1 |
Kyoda, Y; Maehana, T; Takayanagi, A; Yanase, M | 1 |
Choi, KH; Han, DS; Han, SH; Kang, EW; Kang, SW; Lee, HC; Yoo, TH; Yoon, HS; Yoon, SJ | 1 |
Hasegawa, H; Kobayashi, Y; Komuro, I; Kuwabara, Y; Mizuma, H; Narumi, H; Shindo, S; Takano, H | 1 |
Bagci, G; Koksal, B; Kurtulgan, HK; Ozdemir, O; Sezgin, I | 1 |
Brown, NJ; Gamboa, JL; Ikizler, TA; Luther, JM; Pretorius, M; Todd-Tzanetos, DR; Yu, C | 1 |
Bassi, R; Caldara, R; De Cobelli, F; Del Maschio, A; Fiorina, P; Gremizzi, C; Mello, A; Perseghin, G; Secchi, A; Vergani, A | 1 |
Deda, E; Grapsa, E; Kostis, E; Pantelias, K; Pipili, C; Tsiamalos, P | 1 |
Chen, Z; Li, CC; Liu, X; Lou, T; Peng, H; Wang, C; Ye, ZC; Zhang, J | 1 |
Eiam-Ong, S; Seublinvong, T; Tasanarong, A | 1 |
Krum, H; Martin, J | 1 |
Iwasawa, H; Matsumoto, H; Nagaoka, Y; Nakao, T; Nanri, K; Okada, T; Yamazaki, T | 1 |
Beaulieu, J; Dworkin, L; Gohh, R; Monaco, A; Morrissey, P; Shemin, D; Yango, A; Zanabli, A | 1 |
Rivkin, AM | 1 |
Barrett, PH; Berger, R; Bisschop, PH; de Barse, MM; de Boer, J; de Sain-van der Velden, MG; Prinsen, BH; Rabelink, TJ; Romijn, JA; van Haeften, TW | 1 |
Kanno, Y; Nakamoto, H; Okada, H; Sugahara, S; Suzuki, H | 1 |
Cooper, ME; Thomas, MC | 1 |
Delgado López, F; Franco Macías, E; Rodríguez Uranga, JJ; Villalobos Chávez, F | 1 |
Beirão, I; Bravo, F; Cabrita, A; Costa, PM; Fonseca, I; Lobato, L; Mendes, P; Porto, G; Silva, M | 1 |
Delcroix, C; Ekhlas, A; Esnault, VL; Moutel, MG; Nguyen, JM | 1 |
Bakran, A; Dhanda, RK; Hold, PM; Walkinshaw, SA; Wong, CF | 1 |
Dilek, I; Dogan, E; Durmus, A; Erkoc, R; Sayarlioglu, H; Topal, C | 1 |
Das, V; Legendre, C; Peraldi, MN | 1 |
Iigaya, K; Kumagai, H; Onami, T; Saruta, T; Takimoto, C | 1 |
Averbukh, Z; Berman, S; Efrati, S; Galperin, E; Malcev, E; Manevits, E; Rosenberg, R; Weissgarten, J | 1 |
Aslam, S; Leone, A; Santha, T; Wilcox, C | 1 |
Zoccali, C | 1 |
Esaki, M; Fujiwara, H; Fujiwara, T; Kanamori, H; Kondo, T; Li, L; Li, Y; Maruyama, R; Minatoguchi, S; Miyata, S; Nakagawa, M; Ogino, A; Ohno, T; Okada, H; Takemura, G | 1 |
Acikel, C; Caglar, K; Cakir, E; Eyileten, T; Kurt, Y; Oguz, Y; Saglam, M; Sonmez, A; Tasar, M; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
Bruzzone, M; Deferrari, G; Garibotto, G; Lutman, M; Passerone, G; Robaudo, C; Tizianello, A | 1 |
Croft, MR; Hobson, SM; Parsons, FM; Swanepoel, CR; Young, GA | 1 |
Deferrari, G; Fiorini, F; Garibotto, G; Paoletti, E; Robaudo, C; Russo, R; Tizianello, A | 1 |
Bünten, B; Grabensee, B; Németh, R; Plum, J | 2 |
Aldigier, JC; Botteri, F; Mann, JF; Oddou-Stock, P; Ponticelli, C; Ruilope, LM | 1 |
Ganten, D; Geiger, H; Hartner, A; Hilgers, KF; Hugo, C; Mai, M; Mann, JF; Porst, M; Veelken, R; Wittmann, M | 1 |
Holecek, M; Sprongl, L; Tichý, M; Tilser, I | 1 |
Fialkow, RZ; Haria, DM; Maru, MC | 1 |
Coats, AJ | 1 |
Kozlovskaia, NL; Medvedeva, TIu; Miroshnichenko, NG; Okonova, EB; Plieva, OK; Rudenko, TE; Shonichev, DG; Shvetsov, MIu; Stavrovskaia, EV | 1 |
Dhillon, S; Stathakis, C; Stathoulopoulou, F; Thodis, H; Vargemezis, V | 1 |
Richards, P | 1 |
Jones, MR; Kopple, JD | 1 |
Barron, JL; Bending, MR; Carr, EC; Kwan, JT | 1 |
Hara, Y; Kelly, RA; May, RC; Mitch, WE | 1 |
Betuel, H; Cirillo, D; Esposito, R; Fredel, A; Giordano, C; Lanzetti, N; Manzo, M; Perna, N; Pluvio, M | 1 |
Arai, J; Fukuda, S; Hara, Y; Sugino, N; Takuma, T | 1 |
Brown, CL; Houghton, BJ; Richards, P; Thompson, E | 1 |
Klimkiewicz, E; Szewczyk, Z | 1 |
Comty, CM; Shapiro, F; Wathen, RL | 1 |
10 review(s) available for valine and Kidney Failure, Chronic
Article | Year |
---|---|
Reduction of proteinuria with angiotensin receptor blockers.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Cardiovascular Diseases; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Valacyclovir neurotoxicity: clinical experience and review of the literature.
Topics: Acute Kidney Injury; Acyclovir; Adult; Aged; Antiviral Agents; Consciousness Disorders; Female; Hallucinations; Herpes Zoster; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neurotoxicity Syndromes; Valacyclovir; Valine | 2009 |
Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cytoprotection; Humans; Hypertension; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Models, Biological; Renin-Angiotensin System; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Myocardial Infarction; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2002 |
Blockade of the renin-angiotensin system: better late than never.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Complications; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Peritoneal Dialysis, Continuous Ambulatory; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2004 |
[Molecular mechanisms underlying proteinuria reduction and protection of nephrin and podocytes by ARB].
Topics: Actinin; Actins; Adaptor Proteins, Signal Transducing; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Cytoskeletal Proteins; Humans; Intracellular Signaling Peptides and Proteins; Kidney Failure, Chronic; Membrane Proteins; Podocytes; Proteins; Proteinuria; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan | 2006 |
Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism?
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Biomarkers; Calcium; Calcium Channel Blockers; Humans; Kidney Failure, Chronic; Risk Factors; Tetrazoles; Valine; Valsartan | 2006 |
Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Diabetes Mellitus, Type 2; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Losartan; Tetrazoles; Valine; Valsartan | 2001 |
Protein metabolism in uraemia.
Topics: Adult; Amino Acids; Amino Acids, Essential; Ammonia; Blood Urea Nitrogen; Dietary Proteins; Feces; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitrogen; Nutrition Disorders; Nutritional Requirements; Proteins; Renal Dialysis; Serum Albumin; Urea; Urease; Uremia; Valine | 1975 |
[Role of essential amino acids in the treatment of chronic renal failure].
Topics: Age Factors; Amino Acids; Diet Therapy; Diuresis; Glomerular Filtration Rate; Humans; Isoleucine; Kidney Failure, Chronic; Leucine; Lysine; Methionine; Nitrogen; Phenylalanine; Threonine; Tryptophan; Uremia; Valine | 1972 |
24 trial(s) available for valine and Kidney Failure, Chronic
Article | Year |
---|---|
Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial.
Topics: Antiviral Agents; Carbamates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Outcome and Process Assessment, Health Care; Prospective Studies; Pyrrolidines; Renal Dialysis; Sofosbuvir; Valine | 2019 |
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.
Topics: Adult; Aged; Aminoisobutyric Acids; Antiviral Agents; Biopsy, Needle; Calcineurin Inhibitors; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Glucose Intolerance; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Kidney Failure, Chronic; Kidney Transplantation; Lactams, Macrocyclic; Leucine; Liver; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Pyrrolidines; Quinoxalines; RNA, Viral; Salvage Therapy; Sofosbuvir; Sulfonamides; Treatment Outcome; Valine; Viral Load; Viral Nonstructural Proteins; Viremia | 2019 |
Short-term administration of an angiotensin II receptor blocker in patients with long-term hemodialysis patients improves insulin resistance.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Glucose; Female; Humans; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Tetrazoles; Valine; Valsartan | 2014 |
Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment.
Topics: Antiviral Agents; Carbamates; Female; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Pyrrolidines; Valine; Viral Nonstructural Proteins | 2015 |
Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.
Topics: Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Sulfonamides; Treatment Outcome; Valine | 2016 |
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2016 |
Efficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study).
Topics: Aged; Antihypertensive Agents; Biphenyl Compounds; Cross-Over Studies; Female; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Female; Humans; Incidence; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Renal Dialysis; Tetrazoles; Valine; Valsartan | 2008 |
Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptides; Peritoneal Dialysis, Continuous Ambulatory; Pulse; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2009 |
Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis.
Topics: Angiotensin II Type 1 Receptor Blockers; Brachial Artery; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Prognosis; Prospective Studies; Tetrazoles; Valine; Valsartan; Vascular Resistance; Vascular Stiffness; Vasodilation | 2011 |
Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART.
Topics: Aged; Albuminuria; Amlodipine; Angina Pectoris; Antihypertensive Agents; Asian People; Blood Pressure; Cardiovascular Diseases; Cause of Death; Creatinine; Death, Sudden; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2012 |
Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation; CD40 Ligand; Cross-Over Studies; Cytokines; Double-Blind Method; Female; Hemodynamics; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Ramipril; Renal Dialysis; Renin; Tetrazoles; Valine; Valsartan | 2012 |
31P-magnetic resonance spectroscopy (31P-MRS) detects early changes in kidney high-energy phosphate metabolism during a 6-month Valsartan treatment in diabetic and non-diabetic kidney-transplanted patients.
Topics: Adult; Angiotensin Receptor Antagonists; Female; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphates; Tetrazoles; Valine; Valsartan | 2012 |
Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Drug Chronotherapy; Echocardiography; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2013 |
Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Creatinine; Female; Humans; Hypertension; Japan; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Cavity; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Proteinuria; Retrospective Studies; Tetrazoles; Urine; Valine; Valsartan | 2004 |
Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents.
Topics: Adult; Aged; Antihypertensive Agents; Cross-Over Studies; Diet, Sodium-Restricted; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Reference Values; Risk Assessment; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2005 |
Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Urea Nitrogen; Creatinine; Erythropoietin; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Tetrazoles; Uric Acid; Valine; Valsartan | 2005 |
Blockade of renin-angiotensin system reduces QT dispersion and improves intracellular Ca/Mg status in hemodialysis patients.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Calcium; Cilazapril; Female; Heart Rate; Humans; In Vitro Techniques; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Renal Dialysis; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2006 |
Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Arginine; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Methylation; Middle Aged; Oxidative Stress; Renal Dialysis; Tetrazoles; Valine; Valsartan | 2006 |
Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Glomerular Filtration Rate; Hemorheology; Humans; Insulin Resistance; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Proteinuria; Ramipril; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Vasodilation | 2007 |
Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
Topics: Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Creatinine; Dextrans; Double-Blind Method; Erythrocyte Count; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inulin; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Molecular Weight; p-Aminohippuric Acid; Particle Size; Potassium; Prospective Studies; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan | 1998 |
Treatment with the angiotensin II antagonist valsartan in patients with chronic renal failure and hypertension.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Renal Circulation; Tetrazoles; Valine; Valsartan | 1999 |
Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Creatinine; Drug Combinations; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Pilot Projects; Potassium; Proteinuria; Safety; Tetrazoles; Valine; Valsartan | 2000 |
[Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
Topics: Adult; Antihypertensive Agents; Chronic Disease; Female; Follow-Up Studies; Glomerulonephritis; Humans; Hypertension; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Proteinuria; Tetrazoles; Time Factors; Valine; Valsartan | 2001 |
54 other study(ies) available for valine and Kidney Failure, Chronic
Article | Year |
---|---|
Development and Validation of a New LC-MS/MS Analytical Method for Direct-Acting Antivirals and Its Application in End-Stage Renal Disease Patients.
Topics: Adult; Anilides; Antiviral Agents; Carbamates; Chromatography, Liquid; Cyclopropanes; Drug Stability; Female; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Mass Spectrometry; Middle Aged; Plasma; Proline; Ritonavir; Sulfonamides; Valine | 2020 |
Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.
Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; RNA, Viral; Statistics, Nonparametric; Sulfonamides; Sustained Virologic Response; Time Factors; Treatment Outcome; Uracil; Valine; Young Adult | 2019 |
Effect of Hemodialysis on Efficacy and Pharmacokinetics of Sofosbuvir Coformulated with Either Daclatasvir or Ledipasvir in Patients with End-Stage Renal Disease.
Topics: Adult; Aged; Benzimidazoles; Carbamates; Clinical Trials as Topic; Drug Monitoring; Drug Therapy, Combination; Female; Fluorenes; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Sofosbuvir; Treatment Outcome; Valine | 2020 |
Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience.
Topics: Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Egypt; Female; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Valine | 2020 |
Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Carbamates; Donor Selection; Drug Therapy, Combination; Female; Fluorenes; Follow-Up Studies; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postoperative Care; Pyrrolidines; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Tissue Donors; Treatment Outcome; Valine | 2017 |
Valacyclovir-associated neurotoxicity treated with intensification of peritoneal dialysis.
Topics: Acyclovir; Administration, Intravenous; Antiviral Agents; Confusion; Consciousness Disorders; Diagnosis, Differential; Encephalitis, Herpes Simplex; Female; Herpes Zoster; Humans; Kidney Failure, Chronic; Middle Aged; Neurotoxicity Syndromes; Peritoneal Dialysis; Valacyclovir; Valine | 2017 |
Successful treatment of chronic hepatitis C virus infection in a patient receiving daily peritoneal dialysis.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Administration Schedule; Drug Combinations; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Peritoneal Dialysis; Proline; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine | 2017 |
Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Pyrrolidines; Renal Dialysis; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine; Young Adult | 2018 |
Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease.
Topics: Adult; Antiviral Agents; Carbamates; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Pyrrolidines; Severity of Illness Index; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2018 |
'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
Topics: Aged; Antiviral Agents; Benzimidazoles; Carbamates; Cohort Studies; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate; Valine | 2018 |
Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Regimen in the Treatment of Genotype 1 Chronic Hepatitis C Infection in Patients with Severe Renal Impairment and End-Stage Renal Disease: a Real-Life Cohort.
Topics: 2-Naphthylamine; Anilides; Antihypertensive Agents; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Renal Insufficiency; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine | 2018 |
Three renal failure cases successfully treated with ombitasvir/paritaprevir/ritonavir for genotype 1b hepatitis C virus reinfection after liver transplantation.
Topics: Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lactams, Macrocyclic; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Proline; Ritonavir; Sulfonamides; Valine; Virus Activation | 2019 |
Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease.
Topics: Adult; Aged, 80 and over; Algorithms; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Combinations; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Valine | 2019 |
Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey.
Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Renal Dialysis; Ritonavir; Sulfonamides; Sustained Virologic Response; Turkey; Uracil; Valine | 2019 |
Successful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant Recipients.
Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Retrospective Studies; Ribavirin; Risk Factors; Ritonavir; Sulfonamides; Sustained Virologic Response; Time Factors; Treatment Outcome; Uracil; Valine | 2019 |
¹H NMR spectroscopic quantification of plasma metabolites in dialysate during hemodialysis.
Topics: Aged; Alanine; Biomarkers; Blood Chemical Analysis; Creatinine; Dialysis Solutions; Female; Humans; Kidney Failure, Chronic; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Protons; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Valine | 2013 |
Metabolic responses during hemodialysis determined by quantitative (1)H NMR spectroscopy.
Topics: Aged; Alanine; Creatinine; Female; Humans; Kidney Failure, Chronic; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pyruvic Acid; Renal Dialysis; Valine | 2015 |
Treatment of chronic hepatitis C with direct acting antiviral agents in patients with haemophilia, end-stage liver disease and coinfected with HIV.
Topics: Adult; Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Coinfection; Drug Interactions; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Pyrrolidines; RNA, Viral; Sofosbuvir; Treatment Outcome; Valine; Viral Load | 2016 |
Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients.
Topics: Antiviral Agents; Carbamates; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Ribavirin; RNA, Viral; Sofosbuvir; Sustained Virologic Response; Valine; Viral Load | 2016 |
Periodic synchronous discharge occurred in an elderly with acute valacyclovir-associated encephalopathy.
Topics: Acute Disease; Acyclovir; Aged, 80 and over; Antiviral Agents; Brain Diseases; Electroencephalography; Female; Herpes Zoster; Humans; Kidney Failure, Chronic; Periodicity; Valacyclovir; Valine | 2016 |
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Male; Middle Aged; Proline; Renal Dialysis; Ritonavir; Severity of Illness Index; Sulfonamides; Treatment Outcome; Uracil; Valine | 2017 |
Influence of ALDH2 genetic polymorphisms on aciclovir pharmacokinetics following oral administration of valaciclovir in Japanese end-stage renal disease patients.
Topics: Acyclovir; Administration, Oral; Adult; Aged; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Female; Guanine; Half-Life; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Genetic; Prodrugs; Renal Dialysis; Valacyclovir; Valine | 2008 |
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins E; Bezafibrate; Child; Child, Preschool; Enalapril; Female; Hematuria; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Nephrotic Syndrome; Probucol; Tetrazoles; Valine; Valsartan | 2009 |
Distinctly different purpura on different arms.
Topics: Acyclovir; Adult; Antiviral Agents; Arm; Ecchymosis; Female; Giant Cells; Herpes Zoster; Histological Techniques; Humans; Kidney Failure, Chronic; Lupus Nephritis; Purpura; Thrombocytopenia; Valacyclovir; Valine | 2009 |
Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Survival; Humans; Incidence; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prodrugs; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Valacyclovir; Valganciclovir; Valine | 2010 |
Valacyclovir neurotoxicity can be effectively managed by hemodialysis.
Topics: Acyclovir; Antiviral Agents; Female; Herpes Zoster; Humans; Kidney Failure, Chronic; Middle Aged; Neurotoxicity Syndromes; Renal Dialysis; Valacyclovir; Valine | 2011 |
[Neurotoxicity of valacyclovir in a peritoneal dialysis patient].
Topics: Acyclovir; Aged; Antiviral Agents; Humans; Kidney Failure, Chronic; Male; Mental Disorders; Peritoneal Dialysis; Valacyclovir; Valine | 2010 |
CCR2 polymorphism in chronic renal failure patients requiring long-term hemodialysis.
Topics: Adult; Aged; Female; Gene Frequency; Genotype; Humans; Isoleucine; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Genetic; Receptors, CCR2; Renal Dialysis; Time Factors; Valine | 2011 |
Intensification of peritoneal dialysis improves valacyclovir neurotoxicity.
Topics: Acute Kidney Injury; Acyclovir; Aged; Antiviral Agents; Female; Follow-Up Studies; Herpes Zoster; Humans; Kidney Failure, Chronic; Kidney Function Tests; Peritoneal Dialysis, Continuous Ambulatory; Risk Assessment; Treatment Outcome; Valacyclovir; Valine | 2013 |
The role of carbamylated hemoglobin in identifying acute and chronic renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Chromatography, High Pressure Liquid; Female; Hemoglobin A; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; ROC Curve; Valine | 2002 |
Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis.
Topics: Acyclovir; Aged; Antiviral Agents; Dose-Response Relationship, Drug; Humans; Kidney Failure, Chronic; Male; Neurotoxicity Syndromes; Peritoneal Dialysis, Continuous Ambulatory; Valacyclovir; Valine | 2002 |
Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.
Topics: Acyclovir; Administration, Oral; Adult; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Opportunistic Infections; Preoperative Care; Probability; Retrospective Studies; Risk Assessment; Treatment Outcome; Valacyclovir; Valine | 2003 |
Valacyclovir-induced seizures in end-stage renal disease.
Topics: Acyclovir; Aged; Humans; Kidney Failure, Chronic; Male; Seizures; Valacyclovir; Valine | 2003 |
A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.
Topics: Acetates; Adult; Apolipoprotein B-100; Apolipoproteins B; Carbon Isotopes; Cholesterol, VLDL; Deuterium; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin; Kidney Failure, Chronic; Lipolysis; Male; Middle Aged; Palmitates; Peritoneal Dialysis; Valine | 2004 |
[Epilepticus status and valaciclovir in chronic renal failure].
Topics: Acyclovir; Aged; Aged, 80 and over; Anticonvulsants; Antiviral Agents; Female; Herpes Zoster; Humans; Kidney Failure, Chronic; Status Epilepticus; Treatment Outcome; Valacyclovir; Valine | 2004 |
Kidney and anemia in familial amyloidosis type I.
Topics: Adult; Aged; Amyloid Neuropathies, Familial; Anemia; Autonomic Nervous System Diseases; Case-Control Studies; Cross-Sectional Studies; Erythropoietin; Female; Heterozygote; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Mutation; Portugal; Prealbumin; Prevalence; Retrospective Studies; Valine | 2004 |
[Type 2 diabetic patient with kidney damage. Sartans banish dialysis risk].
Topics: Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Renal Dialysis; Tetrazoles; Valine; Valsartan | 2004 |
Successful renal transplantation during pregnancy.
Topics: Acyclovir; Adult; Cyclosporine; Family Health; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy, High-Risk; Time Factors; Treatment Outcome; Valacyclovir; Valine | 2005 |
Adverse neuropsychiatric effects of cytomegalovirus prophylaxis with valaciclovir in renal transplant recipients.
Topics: Acyclovir; Adult; Age Distribution; Analysis of Variance; Behavioral Symptoms; Cohort Studies; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; France; Graft Rejection; Humans; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Neuropsychological Tests; Probability; Prognosis; Retrospective Studies; Risk Assessment; Sex Distribution; Valacyclovir; Valine | 2006 |
Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Urea Nitrogen; Blotting, Western; Creatinine; Disease Models, Animal; DNA; Heart Failure; Immunohistochemistry; Kidney Failure, Chronic; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nephrectomy; Oxidative Stress; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Treatment Outcome; Up-Regulation; Valine; Valsartan; Ventricular Function, Left | 2007 |
Branched-chain amino acid metabolism in chronic renal failure.
Topics: Adult; Aged; Brain; Female; Humans; Isoleucine; Kidney; Kidney Failure, Chronic; Leg; Leucine; Male; Middle Aged; Splanchnic Circulation; Valine | 1983 |
Anthropometry and plasma valine, amino acids, and proteins in the nutritional assessment of hemodialysis patients.
Topics: Adolescent; Adult; Amino Acids; Anthropometry; Blood Proteins; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Protein-Energy Malnutrition; Renal Dialysis; Valine | 1982 |
Peripheral metabolism of branched-chain keto acids in patients with chronic renal failure.
Topics: Adult; Amino Acids, Branched-Chain; Bicarbonates; Female; Hemiterpenes; Humans; Isoleucine; Keto Acids; Kidney Failure, Chronic; Leucine; Male; Middle Aged; Valine | 1993 |
Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Chemokine CCL2; Chemotaxis, Leukocyte; Gene Expression; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Macrophages; Monocytes; Nephrosclerosis; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Mutant Strains; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2000 |
Leucine and protein metabolism in rats with chronic renal insufficiency.
Topics: Acidosis; Animals; Body Weight; Cholesterol; Creatinine; Disease Models, Animal; Eating; Isoleucine; Kidney Failure, Chronic; Leucine; Male; Muscle, Skeletal; Nephrectomy; Proteins; Rats; Rats, Wistar; Urea; Uremia; Valine | 2001 |
Choreiform movements in dialysis patient taking valacyclovir and famciclovir.
Topics: 2-Aminopurine; Acyclovir; Aged; Aged, 80 and over; Chorea; Drug Interactions; Famciclovir; Herpes Zoster; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Valacyclovir; Valine | 2001 |
Evaluation of valaciclovir dosage reduction in continuous ambulatory peritoneal dialysis patients.
Topics: Acyclovir; Aged; Antiviral Agents; Biological Availability; Female; Herpes Zoster; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Valacyclovir; Valine | 2002 |
Valine metabolism in normal and chronically uremic man.
Topics: Adult; Aged; Carbon Dioxide; Chronic Disease; Decarboxylation; Dietary Proteins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Oxidation-Reduction; Uremia; Valine | 1978 |
Determination of carbamylated hemoglobin by high-performance liquid chromatography.
Topics: Buffers; Chromatography, High Pressure Liquid; Creatine; Diabetes Mellitus; Hemoglobin A; Humans; Hydrogen-Ion Concentration; Hydrolysis; Kidney Failure, Chronic; Mathematics; Urea; Uremia; Valine | 1990 |
Acidosis, not azotemia, stimulates branched-chain, amino acid catabolism in uremic rats.
Topics: Acidosis; Amino Acids, Branched-Chain; Animals; Dietary Proteins; Kidney Failure, Chronic; Leucine; Male; Muscles; Nephrectomy; Rats; Rats, Inbred Strains; Uremia; Valine | 1987 |
The effect of branch chain amino acids on the proliferation of normal and uremic cells.
Topics: Cell Division; Cells, Cultured; Humans; Isoleucine; Kidney Failure, Chronic; Leucine; Lymphocytes; Renal Dialysis; Uremia; Valine | 1985 |
Metabolic conversion of alpha-keto valine to valine in patients with chronic renal failure.
Topics: Administration, Oral; Energy Intake; Hemiterpenes; Humans; Keto Acids; Kidney Failure, Chronic; Valine | 1985 |
Synthesis of phenylalanine and valine by healthy and uraemic men.
Topics: Adult; Amino Acids; Ammonium Chloride; Carbon; Diet; Female; Glycine; Humans; Keto Acids; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Nitrogen; Nitrogen Isotopes; Phenylalanine; Phosphates; Serum Albumin; Sulfur; Time Factors; Urea; Uremia; Valine | 1971 |
Protein metabolism in renal failure.
Topics: Amino Acids, Essential; Ammonia; Arginine; Blood Urea Nitrogen; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Eggs; Hemoglobins; Histidine; Humans; Intestinal Absorption; Kidney Failure, Chronic; Kidney Transplantation; Nitrogen Isotopes; Nutritional Requirements; Phenylalanine; Renal Dialysis; Transplantation, Homologous; Tryptophan; Urea; Valine | 1973 |